Gainers
Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-211.
Gainers
Tuesday Morning (NASDAQ:TUEM) shares rose 71.8% to $0.73 during Monday's after-market session. The market value of their outstanding shares is at $4.3 million.